Evidence map›Paper›PMID 40943591›Full record

ArticleInternational journal of molecular sciences2025

BlihIA-A Novel Type I Restriction-Modification System from

Anna Kudryavtseva, Rodion Berezov, Anna Utkina, Oksana Kotovskaya, Mikhail Skutel, Anna Trofimova, Artem Isaev, Ilya Manukhov

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Anna KudryavtsevaMoscow Center for Advanced Studies, Moscow 121059, Russia.ORCID 0000-0001-7274-877X
Rodion BerezovMoscow Center for Advanced Studies, Moscow 121059, Russia.
Anna UtkinaMoscow Center for Advanced Studies, Moscow 121059, Russia.
Oksana KotovskayaCenter for Molecular and Cellular Biology, Moscow 121205, Russia.
Mikhail SkutelCenter for Molecular and Cellular Biology, Moscow 121205, Russia.
Anna TrofimovaCenter for Molecular and Cellular Biology, Moscow 121205, Russia.
Artem IsaevCenter for Molecular and Cellular Biology, Moscow 121205, Russia.ORCID 0000-0002-9593-2745
Ilya ManukhovMoscow Center for Advanced Studies, Moscow 121059, Russia.

Funding

Russian Science Foundation 24-74-00024
6 · The paper itself

Abstract

Type I restriction-modification (RMI) systems play a crucial role in bacterial defense against mobile elements by distinguishing self and foreign DNA through sequence-specific methylation and cleavage. Here, we characterize BlihIA, a novel RMI system from

Indexed as

Bacillus licheniformisBacterial ProteinsDNA Restriction-Modification EnzymesDNA, BacterialDNA CleavagePlasmidsBacterial ProteinsDNA, BacterialDNA Restriction-Modification Enzymesantirestriction proteinsArdBBlihIAmethylationONT sequencingrestriction-modification

Identifiers

PMID40943591
PMCPMC12429846

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.